Jubilant Cadista Pharmaceuticals, Inc. has recalled approximately 1,313,333 Lamotrigine (generic Lamictal) 150 mg tablets. This recall was initiated because foreign substances, visually consistent with silica granules from desiccant packs used during storage, were found in the bulk product. These tablets were shipped in bulk containers for repackaging and may have reached consumers through prescriptions filled after the distribution in Tennessee. If you have been prescribed this medication, please consult your healthcare provider or pharmacist regarding your supply.
The presence of foreign silica granules in the medication poses a risk of choking or irritation if swallowed. While the risk is considered low, consuming foreign materials not intended for medicinal use can cause physical discomfort or interfere with the proper dosage of the drug.
Return to pharmacy for refund and consultation.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.